Clinical Trial Update: New Castle Disease Virus (NDV) in Glioblastoma Multiforme (GBM), Sarcoma and Neuroblastoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update notes that the Newcastle Disease Virus (NDV) therapy trial for Glioblastoma, Sarcoma, and Neuroblastoma has been withdrawn (Phase 1/2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Neuroblastoma
• Sarcoma

Drugs mentioned

• Newcastle Disease Virus (NDV) (Newcastle disease virus)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Glioblastoma, Sarcoma | Phase 1, Phase 2 | Status: WITHDRAWN